Skip to content
Think Research Logo
  • For Clinicians
    • Clinical Content
      • Order Sets
      • LTC Clinical Support Tools
    • Clinical Education
      • MDBriefCase
      • Oncology Education
    • Clinical Connectivity
      • eReferrals
      • VirtualCare
      • eForms
      • Digital Front Door
      • Pharmapod
    • Clinical Research
      • BioPharma Services
  • For Investors
    • Resources
      • Press Releases
      • Financials
    • Media
      • Media Coverage
      • Video Interviews
    • Corporate Governance
      • Governance Documents
      • Board Charters
    • Investor Hub
  • Company
    • About Think Research
    • Leadership
    • Careers
    • News
    • Events
  • Resources
    • Resources Hub
    • Blog
  • Contact Us
Menu
  • For Clinicians
    • Clinical Content
      • Order Sets
      • LTC Clinical Support Tools
    • Clinical Education
      • MDBriefCase
      • Oncology Education
    • Clinical Connectivity
      • eReferrals
      • VirtualCare
      • eForms
      • Digital Front Door
      • Pharmapod
    • Clinical Research
      • BioPharma Services
  • For Investors
    • Resources
      • Press Releases
      • Financials
    • Media
      • Media Coverage
      • Video Interviews
    • Corporate Governance
      • Governance Documents
      • Board Charters
    • Investor Hub
  • Company
    • About Think Research
    • Leadership
    • Careers
    • News
    • Events
  • Resources
    • Resources Hub
    • Blog
  • Contact Us
  • Book Demo
Menu
  • Book Demo

Think Research News

ThinkResearch-Logo

Think Research Announces Payment of Deferred Consideration by Issuance of Common Shares

TORONTO, ON – December 30,  2022 – Think Research Corporation (TSXV: THNK) (“Think” or the “Company”), a company focused on transforming healthcare through digital health software solutions, today

Read More »
ThinkResearch-Logo

Think Research Announces Grant of Equity Compensation

TORONTO, ON – December 21, 2022 – Think Research Corporation (TSXV: THNK) (“Think” or the “Company”), a company focused on transforming healthcare through integrated digital

Read More »
Think Research logo

Think Research Announces Closing of $2.5 Million First Tranche of Previously Announced Equity Financing

TORONTO, ON – December 19, 2022 – Think Research Corporation (TSXV: THNK) (“Think” or the “Company”), an innovative disruptor focused on transforming healthcare through digital health software solutions, is

Read More »
Think Research logo

Correction: Think Research Announces Third Quarter 2022 Financial and Operational Results Highlighted by Strong Revenue Growth and Continued Cost Synergies; Closes Subsequent Advance with Beedie Captial

Q3 revenue of $18.4 million grew 82% over the same period in 2021 99% revenue growth to $57.0 million in the first nine months of

Read More »
Think Research logo

Think Research Announces Date of Third Quarter 2022 Earnings Release and Conference Call Details

Earnings to be announced by the Company before the market opens on November 28, 2022 TORONTO, ON – November 25, 2022  — Think Research Corporation (TSXV:THNK)(OTC: THKKF)

Read More »
Think Research logo

Think Research Enhances Financial Flexibility with New Capital Injection and Announces Amendments to Convertible Loan Facility with Beedie Capital

Additional $3 million to be received via second advance under $25 million convertible loan facility with Beedie Capital Infusion of $3 million of liquidity via

Read More »
Think Research logo

Think Research Corporation Amends Certain Terms Relating to the BioPharma Acquisition

TORONTO, ON, October 14, 2022 – Think Research Corporation (TSXV:THNK) (“Think” or the “Company”), a healthcare technology company focused on transforming healthcare through knowledge-based digital health

Read More »
Think Research logo

Think Research Announces Withdrawal from OTCQB

TORONTO, ON – October 7, 2022 – Think Research Corporation (TSXV: THNK) (“Think” or the “Company”), a company focused on transforming healthcare through integrated digital health

Read More »
Think Research logo

Think Research Corporation Announces Amended Debt Facility with ScotiaBank and Termination of Agreement with PI Financial

Amended Credit Agreement with The Bank of Nova Scotia to update and align its terms with its existing credit facilities with Beedie Capital. TORONTO, ON –

Read More »
Think Research logo

Think Research Announces Grant of Equity Compensation

TORONTO, ON – September 22, 2022 – Think Research Corporation (TSXV: THNK) (“Think” or the “Company”), a company focused on transforming healthcare through integrated digital

Read More »
Think Research logo

Think Research Appoints John Hayes as Permanent Chief Financial Officer

Also promotes Patrick Craib to Chief Operating Officer. Both appointments are expected to significantly contribute to a profitable growth strategy going forward. TORONTO, ON – September 22,

Read More »
Think Research and BioPharma logos

Think Research Announces Approximately $12.8 Million of New BioPharma Contracts Signed During Q3 2022

Revenue recognition commencing in September to October timeframe. Average length of each  program is approximately 12 months. TORONTO, ON – September 20, 2022 – Think Research Corporation (TSX.V:THNK)

Read More »
Think Research logo

Think Research Expands Recent Major Content & Learning Management Agreement with Global Pharmaceutical Company

Recent contract expansions add nearly $2.3M of revenue to the $4.1M contract announced earlier this year. Revenue recognition to commence prior to year-end. TORONTO, ON – September

Read More »
Think Research logo

Think Research Announces Grant of Equity Compensation

TORONTO, ON – August 31, 2022 – Think Research Corporation (TSXV: THNK) (OTCQB: THKKF) (“Think” or the “Company”), a company focused on transforming healthcare through

Read More »
Think Research logo

Think Research Reports Q2 and First Half 2022 Results, Highlighted by Strong Revenue Growth and Continued Cost Synergies

Q2 Revenue totaled $18.4 million, 80% higher than the same period in 2021 First half 2022 revenue grew 108% to $38.6 million compared to the

Read More »
Load More

Contacts

199 Bay Street #4000, Toronto,
ON M5L 1A9

(416) 977-1955

(877) 302-1861

VirtualCare
(800) 559-3041

Follow Us

Twitter Facebook-f Linkedin-in

About Us

Company Overview

Leadership

News

Events

Blog

Careers

Our Companies

BioPharma Services

Clinic 360

HealthCare Plus

MDBriefCase

Oncology Education

Pharmapod

Products

eForms

eReferrals

LTC Clinical Support Tools

Order Sets

Virtual Care

Digital Front Door

Investors

Investor Relations

Media

Corporate Governance

Financials

Support

Help Centre

TxConnect Login

VirtualCare Login

© 2023 All Rights Reserved Think Research Corporation

Accessibility   |   Privacy Policy

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

Think Research Logo
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful. View our full EU privacy and cookie policies.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics and other tools to collect anonymous visitor information.

 

Please enable Strictly Necessary Cookies first so that we can save your preferences!